Oncology Venture advancing in all priority programs 16 december, 2019 Treatment outcomes in cancer care could be significantly improved if there was a way to identify whether or not each individual patient was likely to respond to a specific treatment. Danish biotech Oncology Ven... LÄS MER!
Effective management prioritized by Oncology Venture’s Chairman 11 november, 2019 Last week, BioStock talked to Oncology Venture’s new CEO Steve Carchedi about his vision for the company going forward. Today, we pick up the conversation with the company's chairman, Duncan Moore. How does he ... LÄS MER!
New CEO in Oncology Venture has a stronger commercial market focus 6 november, 2019 Recently, Oncology Venture stepped up in management and replaced both the CEO and the CFO. Subsequently, a new issue of SEK 100 million was announced with pending subscription options for an additional SEK 300 ... LÄS MER!
